Next Generation Sequencing Market Estimated to Witness a Staggering Growth by 2023

 The exclusive research report on the Global Next Generation Sequencing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

Market Research Future’s report on the Global Next Generation Sequencing (NGS) Market divulges key details regarding the growth of the market as well as various vital facts, figures, and prediction of growth of the global market.

Next-generation sequencing (NGS), also termed as high throughput sequencing technology or massively parallel sequencing, has revolutionized the biological sciences. The NGS technology has transformed genomic research to an advanced level and allows to sequence a complete human genome in a small duration. The genetic material is pulled out in this process, fragmented, and associated with primers and adapters for amplification.

Also Read : https://www.medgadget.com/2019/03/2023-next-generation-sequencing-market-research-report-analysis-by-current-industry-growth-size-share-and-services-with-perkinelmer-qiagen-n-v-agilent-technologies-etc.html 

With the emergence of high throughput screening technology, there have been substantial changes in the sequencing process by reduced sequencing cost and offering speed. The technology is propelling at a rapid pace owing to its application in clinical, agricultural, and forensic areas. For instance, NGS helps to detect various clinical applications such as cancer and its infectious disease and several genetic disorders. The augmenting awareness regarding next-generation sequencing, technological advancements, rising acquisitions and mergers among the global players, and growth in genome mapping programs are considered some of the major factors promoting the market growth throughout the appraisal period. NGS allows the researchers to study biological systems and perform a range of applications at a level never before possible with the help of scalability, ultra-high throughput, and speed.

Moreover, NGS is used to execute applications like oncology studies, biomarker discovery, agricultural & animal research, personalized medicine, and others. It has extensively replaced conventional tools of genomics. The demand has further increased across the world due to the increasing R&D investments by several market giants.

Industry Updates

February 18, 2019: QIAGEN N.V. has recently announced an agreement with the Ares Genetics in order to develop innovative bioinformatics and assay solutions to augment research targeting the global health challenges posed by antibiotic-resistant bacteria.

Competitive Dashboard

Oxford Nanopore Technologies, Ltd., BGI, Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo Fisher Scientific, Inc. are among the notable market players that have been included in MRFR’s competition tracking of the global next generation sequencing market.

Segments :

Analysis of the markets several parts are included in MRFR’s segmental analysis which has been performed on the basis of technology, service & product, application, end-user, and region.

The technology used in next-generation sequencing includes whole exome sequencing, CHIP sequencing, whole genome sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and RNA sequencing.

By service & product, the next generation sequencing market has been segmented into consumables, sample preparation, platforms & services for platforms, and sequencing services. The sample preparation segment is further divided into end repair, A-tailing & size selection, quality control, library preparation & target enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned and expounded on in the report.

Applications of next-generation sequencing include genetic screening, drug discovery, diagnostics, agriculture & animal research, and others.

End-users of next-generation sequencing include hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end-users.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354  

Future Scope of Dental 3D Printing Market is Witness to Grow High CAGR till 2023

 An expert on premium research reports, Market Research Future has added a report titled "Global Dental 3D Printing Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Dental 3d printing is a recent technology and is gaining quick recognition due to the rising dental industry and demand for cost-effective tools. The global market for dental 3D printing can grow with a 24.5% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) has revealed various factors like the increasing demand from cosmetic dentistry, rising geriatric population, surging preference for such tools to boost the dental setting, and others. 

But the dental 3D printing market may suffer from stringent regulations, unfavorable reimbursement policies, and others. 

Also Read : https://www.benzinga.com/pressreleases/20/06/ab16185479/dental-3d-printing-market-2020-overview-size-share-industry-swot-analysis-top-companies-product-t

Dental 3D Printing Market Segmentation: 

MRFR made an attempt the understand the global dental 3D printing market by segmenting it into product and service, application, technology, and end-user. These segments have several insights backed by figures and detailed analysis of factors, which will help in boosting the strategy-making procedures.  

By product and service, the global market for dental 3D printing has been segmented into materials, equipment, and services. The equipment segment includes dental 3D scanners and Dental 3D printers. The materials segment comprises plastic, metal, and other materials. 

By technology, the study on the global dental 3D printing market can be segmented into fused deposition modeling, selective laser sintering, polyjet technology, vat Photopolymerization, and other technologies. The vat Photopolymerization can be segmented into stereolithography and digital light processing. 

By application, the global market for dental 3D printing includes orthodontics, prosthodontics, and implantology. The orthodontics segment is expected to gain a substantial boost from the market.  

By end-user, the global market study on dental 3D printing has been segmented into dental hospitals and clinics, dental laboratories, and dental academic and research institutes. The dental academic and research institute segments are enjoying robust funding due to which growth would be easier.  

Dental 3D Printing Market Regional Analysis: 

The Americas would benefit from superlative infrastructure and a better influx of investment as countries like Canada and the US are registering strong uptake to boost their own infrastructure. Europe is also making a profit as countries are evolving as a major medical tourism hub. In Asia Pacific, the market is also making profits due to contributions made by countries like India, China, Japan, and others.  

Dental 3D Printing Market Competitive Landscape: 

The global dental 3D printing market is getting a significant boost from several companies like 3D Systems, Inc., EnvisionTEC, Inc., Stratasys Ltd., Formlabs, Prodways Group, DWS Systems, Renishaw Plc., Concept Laser GmbH, SLM Solutions Group, Carbon, Inc., Rapid Shape GmbH, Asiga, EOS GmbH Electro Optical Systems, and Roland DG. These companies are relying on their actions related to mergers, acquisitions, collaborations, and others. They have also increased their expenditure for the research and development sector, owing to which innovations are happening. This is giving companies an edge in taking the market forward.  

Dental 3D Printing Industry News: 

In April 2020, 3D printing company Rapid Shape and VOCO, a dental material specialist company, announced their partnership that has its target set on providing optimal results and flexibility to their customers. The partnership will enable users of Rapid Shape machines to get access to VOCO’s materials. This will also help VOCO in improving their dental 3D printing portfolio.  

Due to the COVID-19 pandemic outbreak, some of the major sectors in the healthcare industry would enjoy a sluggish growth as they belong to the non-emergency segment. The dental industry is one such sector. Doctors have been advised to reduce their number of cases related to dental surgeries, and people are also preferring to stay away from such appointments owing to which the market may get affected.  

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-3d-printing-market-6260  

Injection Pen Market Foreseen to Draw a Promising Growth by 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Injection Pen Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Global Injection Pen Market Research Report: By Type (Disposable Injection Pens, Others), by Product (Insulin Pens, Pen Needles), by Therapy (Diabetes, Others), by Distribution Channel (Hospital Pharmacies, Others), by End-User – Global Forecast Till 2023

Also Read : https://www.medgadget.com/2020/02/global-injection-pen-market-report-2020-indystry-size-share-global-growth-regional-analysis-competitive-landscape-top-company-profile-future-demand-trends.html 

Injection Pen Market Overview

Healthcare sector is already underway towards revolution with competition amid key players getting intense and growing aggression to develop devices that sync well with latest connected devices. Similarly, injection pen is one of the crucial innovations in the field of drug delivery. Market Research Future estimated that the global injection pen market would attain a CAGR of 6.5% during the forecast period 2017-2023.

Manufacturers recognizing the importance of advanced drug delivery devices, increased investment in digital and healthcare analytics are some of the modern trends that might spur the growth of the global injection pen market. Consumers inclination on personalized and smart products has led to increased demand insights for injection pens. Rapid scaling and sophisticated service offering by the service providers have also helped to uphold the growth of the global market. Moreover, growing prevalence of chronic diseases such as osteoporosis and diabetes are anticipated to drive the global injection pen market. Changing lifestyle, unhygienic food consumption, and a growing number of patients who require daily dose of insulin are some of the factors that are of root disease outbreak, leading to increased numbers in patients.

Big technology players and venture capitalists are bringing high-tech product architectures that are creating lucrative opportunities for the healthcare industries.

Injection Pen Market Competitive players

Industry leaders are rapidly shifting from the beta test and experiments to full-fledged product building. These leading giants include the

• Novo Nordisk
• Ypsomed
• Sanofi
• Owen Mumford
• F. Hoffman-La Roche
• Jiangsu Delfu Medical Device Co. Ltd.
• Pfizer
• Becton Dickinson and Company
• Biocon Ltd.
• Haselmeier
• Merck
• AstraZeneca
• Eli Lilly
• Novartis

Injection Pen Market Segmentation

The rise in R&D activities in drug delivery is anticipated to play a major role in uplifting the growth graph of the global injection pen market during the forecast period.

The global injection pen market is broadly classified based on factors such as type, product, therapy, and end-user.

Based on type, the global injection pen market is bifurcated into disposable injection pens and reusable injection pens.

By product, the global market is segmented into pen needles and insulin pens.

Moreover, the global injection pen market is also segmented based on various therapies such as diabetes, fertility, growth hormone therapy, and osteoporosis.

The end-user segment is classified as home care, hospital, and clinics.

Injection Pen Market Regional Analysis

The Americas dominate the global injection pen market and are expected to maintain its influence during the forecast period. The leading position of the region in the global market is attributed to high adoption rate of injection pens and growing awareness of the drug delivery devices. Existence of leading market giants in Canada and the U.S. is encouraging the growth of the pen injection market in the region.

Following the Americas, Europe has a leading role in the global market, owing to burgeoning diabetics. Growing cases of diabetes have forced manufacturers to develop effective and convenient ways to handle the disease, as diabetes requires day-to-day administration of insulin injections. Thus, feasibility of self-managing the disease has boosted the demand for injection pen in region.

Moreover, the Asia Pacific is an emerging region with immensely growing population; the ratio of patient population with chronic is high. Rise in the figures of diabetics and increased healthcare expenditure has stimulated the growth of the global injection pen market.

The Middle East has the lowest share in the global injection pen market; however, upcoming healthcare investments led by some industrial players is expected to spur the growth rate of the regions.

Injection Pen Industrial updates

Biocorp, healthcare connected device maker has launched a cap for pen injectors that is internet-connected and transmit dosage information to a mobile app. The company stated that it is in talks with Sanofi’s diabetes care platform for negotiations. Its smart sensor cap, named Mallya is the only connected device with injections pens that is accessed to attain the accuracy requirements to achieve CE Class IIb classification by EU regulators. Earlier, in 2016, Companion Medical based in San-Deigo got FDA clearance for the wireless-enabled smart insulin pen, named Inpen.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/injection-pen-market-6146 

Medical Bionic Implant Market: Information, Analytical Insights and growth of 2020 – 2023

 Market Research Future adds the “Medical Bionic Implant Market Research Report - Forecast to 2023” report to their unique collection.

Global medical bionic implant/artificial organs market 2020 are riding high as the medical trades at record prices, and are incredibly showing positive approach and growth prospects in the forecast period (2018–2023). During this period, the market will be attaining a growth rate of 7.0%, and by this, immense growth will be achieved.

Medical Bionic Implant/Artificial Organs Market Growth Boosters & Decliners

Presently, medical bionic implant and artificial organs global market is driven by the fact that large numbers of patients require organ transplantation. The growing advancements in medical technologies are also fueling the global medical bionic implant and artificial organs market.

Also Read : https://www.marketwatch.com/press-release/medical-bionic-implantartificial-organs-market-size-2020-covid-19-impact-analysis-industry-share-growth-analysis-competitive-landscape-key-players-and-regional-revenue-2020-08-25  

Emerging public awareness about assorted diseases, advancements in medical bionic implant and artificial organ procedures, and the requirement for screenings conducted for early diagnosis and treatment of different diseases are also probable to goodwill the global medical bionic implant and artificial organs market in the future. Expiring of the patents of 3D printing might also play pivotal development in 3D printing of artificial organs.

Apart from this, with quick technological advancement, rapid technological advancements in the medical field, ever-escalating medical bionics implants, and artificial organs demand, the global medical bionic implant and artificial organs market is anticipated to have dynamic development in the forecast period.

On the contrary, the factor of the elevated cost linked with organ transplant procedure and cost of medical bionics act as a limit for global medical bionic implant and artificial organs market.

Medical Bionic Implant/Artificial Organs Market Segment Review

The global medical bionic implant/artificial organs market has been studied among the segments of technology, product, fixation, and end-user. 

Technology-wise, the market is classified as mechanical bionics and electronic bionics.

Product-wise, the market is classified as ear bionics, neural/brain bionics, vision bionics, heart bionics, orthopedic bionics, and others. Vision bionics are then again segmented as bionic eye and others. Ear bionics are further segmented as a cochlear implant, and Bone Anchored Hearing Aid (BAHA).

Fixation-wise, the market has included implantable and externally worn.

End-user wise, the market has included research and academic institutes, hospitals and clinics, and others.

Medical Bionic Implant/Artificial Organs Market Regional Framework

The Americas lead the medical bionic implant/artificial organs market owing to the introduction of advanced medical bionic implants by foremost market players. On November 02, 2017, Second Sight Medical Products—a U.S. based company, received the U.S. FDA approval to initiate the Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In the year 2013, the company won the FDA approval for the Argus II retinal prosthesis system.

Europe occupies the second position in the medical bionic implant/artificial organs market. Predictably, the government support towards research and development expenditure and escalating cases of organ failure and related complications are liable to motivate the European market.

The Asia Pacific is the fastest-growing medical bionic implant/artificial organs market owing to a massive patient pool, development in the healthcare technology, and escalating demand for advanced treatments. Healthcare expenditure is found to be advancing in various Asia Pacific regions. Prominent data presented by the Australian Institute of Health and Welfare from 2015 to 2016, the whole health expenditure was USD 170.4 billion, which is 3.6% elevated than the expenditure from 2014 to 2015.

The Middle East and Africa occupy the buck share of the global market owing to lack of technical knowledge, low development, and inadequate medical facilities.

Medical Bionic Implant/Artificial Organs Market Vendors Landscape

Some top vendors in the global medical bionic implant/artificial organs market are listed as Biomet, Inc. (U.S.), Biocontrol Medical (Israel), Cochlear Ltd. (Australia), Boston Scientific Corporation (U.S.), Ekso Bionics (U.S.), Cyberonics, Inc. (U.S.), Medtronic, Inc. (U.S.), LivaNova PLC (U.K), Orthofix International N.V. (The Netherlands), NeuroPace, Inc. (U.S.), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), and St. Jude Medical, Inc. (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051  

Urethral Stricture Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Urethral Stricture Market over the forecast period.

The global urethral stricture market is expected to exhibit a CAGR of 7.30% over the forecast period from 2018 to 2023, according to the latest research report published by Market Research Future (MRFR). The global urethral stricture market is mainly driven by the growing demand for more efficient diagnostic and treatment modalities for urethral and kidney-related conditions. The growing government investment in the healthcare sector is likely to drive the global urethral stricture market over the forecast period.

Also Read : https://www.globenewswire.com/news-release/2019/05/29/1856426/0/en/Urethral-Stricture-Market-to-Garner-USD-1-53-billion-to-expand-at-a-7-30-CAGR-by-2023-Growing-Demand-for-Effective-Medication-to-Drive-Urethral-Stricture-Industry.html 

Urethral strictures refer to a narrowing of the urethra, the last part of the urinary system, which is a tube that excretes the urine outside the body. This can result in pain and difficulty in urinating, including a sensation of not having completely emptied the bladder and retention of urine. These symptoms may make life highly uncomfortable for the patient. This has driven increased research in urethral strictures in recent years, which is likely to be a major driver for the global urethral strictures market over the forecast period. Trauma to the pelvic bone is the most prevalent cause of urethral strictures. The increasing incidence of pelvic bone trauma cases is thus likely to be a key driver for the global urethral strictures market over the forecast period.

The increasing research into the development of effective cures for prostate cancer can also result in increased growth prospects and opportunities in the global urethral stricture market, as urethral strictures have emerged as a key side effect in major projects targeted at discovering effective prostate cancer remedies. This is likely to drive increased research in the field of urethral strictures over the forecast period, leading to steady growth of the global urethral stricture market.

The growing demand for cost-effective medications for urethral strictures is likely to be a defining feature of the global urethral stricture market over the forecast period. Another aspect of this driver is the decreasing popularity of invasive surgeries and the consequent growth in interest in minimally invasive or noninvasive surgeries. This has driven the demand for cost-effective, noninvasive medications for urethral strictures, which is likely to drive steady growth of the global urethral stricture market over the forecast period. The growing geriatric population around the world is also likely to be a major driver for the global urethral stricture market, as urethral strictures are most common in men above 55 years of age.

Competitive Analysis:

Leading players in the global urethral strictures market include Olympus Corporation, Cook Medical Inc., Bard Medical, Boston Scientific Corporation, SRS Medical, Richard Wolf, and Lumentis Ltd.

Segmentation:

The global market for urethral strictures can be segmented by type, condition, cause, treatment, gender, end user, and region.

By type, the global urethral stricture market includes posterior urethral strictures and anterior urethral strictures. The posterior urethral strictures segment is currently dominating the global urethral stricture market and is likely to hold on to its lead over the forecast period due to the increasing development of new drugs capable of dealing with posterior urethral strictures in an effective way.

Based on condition, the global urethral stricture market is segmented into hypospadias & epispadias, urinary incontinence, and others. The hypospadias and epispadias segment dominates the global urethral stricture market and is likely to remain the leading revenue generator over the forecast period due to its increasing prevalence. The segment accounted for USD 468.8 million in 2017 and is expected to exhibit the highest CAGR over the forecast period.

Based on cause, the global urethral stricture market is segmented into iatrogenic, idiopathic, infection-induced, and trauma. The iatrogenic segment accounted for the largest valuation of USD 284 million in 2017 and is likely to exhibit a strong CAGR over the forecast period.

On the basis of treatment, the global urethral strictures market is segmented into urethral dilation, direct vision internal urethrotomy (DVIU), urethroplasty, and others. Urethroplasty is likely to dominate the global urethral stricture market over the forecast period due to its widespread demand. However, the urethral dilation segment is also expected to exhibit a strong CAGR over the forecast period, as this method has received increasing interest over the last few years.

By gender, the male segment accounts for the largest share in the global Urethral Stricture Market and is expected to remain in the lead over the forecast period.

By end use, the global urethral stricture market is segmented into hospitals, ambulatory surgical centers, urologic clinics, and others. Hospitals are likely to dominate the urethral stricture market over the forecast period due to their high throughput of patients.

Regional Analysis:

The Americas are likely to dominate the global urethral stricture market over the forecast period due to the growing prevalence of urethral strictures in the region and the growing availability of effective medications against the condition.

Europe is also likely to hold a considerable share in the global urethral strictures market over the forecast period, following the Americas in terms of total market share.

Asia Pacific is likely to exhibit the highest growth rate over the forecast period due to the growing patient demographic in the region and the growing demand for advancement of the healthcare sector.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/urethral-stricture-market-6001 

MEA HIV Diagnosis & Treatment Research Report And Overview On MEA HIV Diagnosis & Treatment Market to 2023

 Market Scenario:

HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV. Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2990 

Middle East and Africa HIV AIDS Diagnosis & Treatment Market size is growing moderately. Middle East and Africa HIV Diagnosis & Treatment Market is expected to grow at a CAGR of 3.3% and expected to reach US$ 2.07 billion by 2023 from US$ 1.65 billion in 2016.

 Study objectives of Middle East and Africa HIV Diagnosis & Treatment Market:

• To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa HIV Diagnosis & Treatment Market
• To provide insights about factors affecting the market growth in this region
• To analyze the Middle East and Africa HIV Diagnosis & Treatment Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries
• To provide detailed analysis of the market with respect to the current market size and future prospective
• To provide detailed analysis of the market for segments by diagnosis, by treatment, and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle East and Africa HIV Diagnosis & Treatment Market.

Key Players for Middle East and Africa HIV Diagnosis & Treatment Market: 

Some of the key players in this market are: Abbott Laboratories (US), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (US), Cipla Inc. (India), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc.(US), ViiV Healthcare group of companies (UK), Merck & Co., Inc. (US).

Segments:      

Middle East and Africa HIV Diagnosis & Treatment Market has been segmented on the basis of diagnosis which comprise ELISA Test, Saliva Tests, Viral Load Test, Western Blot, and Others. On the basis of treatment, market is segmented into Protease inhibitors (PIs), Non-nucleoside reverse transcriptase inhibitors (NNRTIs), Nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs), Entry or fusion inhibitors, Integrase inhibitors, and others.

Regional Analysis of Middle East and Africa HIV Diagnosis & Treatment Market:                

Considering the scenario of the Middle East and African HIV Diagnosis & Treatment market, Africa is believed to be the largest market for HIV Diagnosis & Treatment. Moreover, the Rest of Middle East and Africa is growing and it is the second largest market for Middle East and Africa HIV Diagnosis & Treatment. On the other hand, UAE market is expected to grow at significant rate in the Middle East and Africa HIV Diagnosis & Treatment during the forecasted period. Saudi Arabia is likely to have a limited but moderate growth in the market.

The report for Middle East and Africa HIV Diagnosis & Treatment Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/hiv-diagnosis-treatment-market-2990 

 

Critical Care Equipment (CCE) Market - Granular Market Report And Review, 2020

  Market Highlights

The Middle East & Africa (MEA) critical care equipment (CCE) market can grow substantially to a valuation of USD 1061.4 million during the forecast period (2017-2023) from a measured valuation of USD 681.2 million in 2016. Market Research Future (MRFR) explains in a detailed report that the leap will take place with an impressive CAGR of 5.7%. The healthcare industry is changing at a rapid rate in the region owing to the need for better treatment. Advents in technology are also aptly backing it up. On the upside, it has a positive impact on critical care which developing fast. The climatic condition of the region triggers many diseases that need immediate, intense care owing to which a revamping of the critical care market is of the utmost importance. Governments in the region have realized the urgency of such developments and the region is also getting global funding.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2751 

However, on the downside, the region has low per capita income, and some of the poorest countries of the world belong here. This could prove detrimental to the otherwise promising market. At the same point of time, awareness among the populace regarding diseases is not so high which can make the MEA CCE market lag behind.

Competitive Scenario:

The region is largely untapped which gives market players ample opportunity to expand their operational boundary. Grabbing this chance with both hands, many multinationals are taking this as a key to explore the uncharted regions further.

Some of the manufacturers contributing the critical care equipment market share are namely Siemens Healthcare Private Limited (Germany), Johnson & Johnson Services, Inc. (US), General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Medtronic (Republic of Ireland), Baxter (US), and others.  

Industry Trends:

The crisis in the region regarding critical care is astounding. Hence, many multinationals and local operatives are working in collaboration to improve the system so that they can reach out to a larger patient pool. Recently, Nyeri County Referral Hospital in Kenya collaborated with Philips to increase their service efficiency by providing the necessary training to their staff and implementing new machines that could prove vital in saving lives.

Trivitron Healthcare Private Limited (“Trivitron”), an Indian market giant, is collaborating with the Investment Funds for Health in Africa (“IFHA”), a leading private equity investor in the healthcare sector in Africa, to launch Trivitron Healthcare Africa B.V. (“THA”), which will have its focus solely on the African continent. This company will provide world-class equipment to the hospitals and research laboratories and a reliable after-sales service.

Segmentation:

The critical care equipment MEA market can be segmented by type of equipment and end-user.

By type of equipment, the CCE market can be segmented into patient monitor, medical ventilator, dialysis, iv pumps, infusion pump, suction apparatus, and others.

Based on end-users, the market includes hospitals, research laboratories, and others. Hospitals constitute 80.60% of the market, and its impact is substantial in the region.

Regional Analysis:

The MEA market for CCE witnesses the U.A.E leading from the front as the country is financially superior and per capita income is quite high. Saudi Arabia is also contributing substantially, and the market is growing in the country. Egypt in Africa registered significant growth. On the other hand, Dubai is emerging as a hub for medical tourism which can change the face of this region. Rest of the MEA countries are going to show slow but steady growth.

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/mea-critical-care-equipment-market-2751